Associated Papers
ctDNA-based liquid biopsy reveals wider mutational profile with therapy resistance and metastasis susceptibility signatures in early-stage breast cancer patients.
Bharde A et al.
The Journal of Liquid Biopsy, 2025
40027235 (PubMed )
Supplement: mmc4.xlsx › Sheet1
DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome.
Todoerti K et al.
Haematologica, 2022
33951891 (PubMed )
Supplement: 2021_278342_TODOERTI_SUPPL.pdf
Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups.
Bolli N et al.
Leukemia, 2018
29789651 (PubMed )
Supplement: 41375_2018_37_MOESM14_ESM.xlsx › supp_Table1
Select a paper to view details